SCHEMBL3321767

SCHEMBL3321767

C/C=C1/CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.60
NR3C2 P08235 5/20 0.60
HSD11B1 P28845 2/20 0.60
HSD11B2 P80365 2/20 0.60
HIF1A Q16665 6/20 0.59
LMNA P02545 5/20 0.59
SHBG P04278 6/20 0.57
SERPINA6 P08185 5/20 0.57
HSD17B10 Q99714 5/20 0.57
MAPK1 P28482 4/20 0.57
MAPT P10636 3/20 0.57
CYP3A4 P08684 3/20 0.57
BLM P54132 3/20 0.57
TSHR P16473 3/20 0.57
NFKB1 P19838 2/20 0.57
CYP2C9 P11712 1/20 0.57
SLC22A2 O15244 1/20 0.57
SLC22A1 O15245 1/20 0.57
SLC22A3 O75751 1/20 0.57
THPO P40225 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3671489 0.88 HIF1A (0.59) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL9459018 0.88 HIF1A (0.59) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL11480876 0.88 HIF1A (0.59) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL30496663 0.88 HIF1A (0.59) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL6013906 0.88 HIF1A (0.59) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL23864218 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL10301232 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL14284911 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL13753020 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A
SCHEMBL20058429 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NR3C2HSD11B1HSD11B2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120736-A1 Mineralocorticoid Receptor Antagonists N.V. ORGANON 2010-05-13 US disclosed
US-20100120736-A1 Mineralocorticoid Receptor Antagonists N.V. ORGANON 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120736-A1 Mineralocorticoid Receptor Antagonists NR3C2, AGTR1, AGTR2 SMN1; SMN2 4419/4885NR3C2 1/4885HSD11B1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.